The PetCure Mission & History
We Understand. We Commit. We Will Help.
PetCure Oncology commits unconditionally to delivering industry-leading cancer care to pets and unwavering support to the families that love them.
At PetCure Oncology, we provide pet families with support, knowledge and access to comprehensive and compassionate cancer care. We share the cancer journey with our patients and their families and believe they deserve the very best in clinical expertise and progressive treatment options.
The following core values exemplify what PetCure Oncology is all about. Every PetCure location and every PetCure employee is committed to being:
PetCure Oncology was created in 2014 by the founders of Accelitech®, the largest privately-held network of stereotactic radiation (SRS/SRT) centers in the human cancer market, in response to a growing need for this technology in veterinary cancer care.
While SRS/SRT is widely available for treating human cancers, the veterinary field has a limited supply of advanced technology and services for treating the growing number of pets with cancer. Radiation equipment is outdated, start-up costs are prohibitive, and there is a significant shortage of board-certified veterinary radiation oncologists in the U.S.
As a result, pet owners have had few options. What’s more, traditional radiation therapy can require dozens of daily visits (and anesthetic events) over a six-week period, and can cause significant side effects for pets. It can also present a serious logistical challenge for pet owners.
As SRS/SRT begins to emerge in veterinary cancer care, early reports indicate good outcomes and fewer side effects than traditional radiation therapy, and pet owners appreciate the significant reduction in daily visits to three or fewer.
Learn more about the PetCure Oncology leadership team
RELATED: PetCure Oncology Forms World-Class Scientific Advisory Board